SUBSCRIBE
SUBSCRIBE
News   Business

Esperion Therapeutics, Inc. Co-Founder Dr. Jan Johansson Joins Resverlogix Corporation As Senior Vice President Of Clinical Affairs

October 19, 2005 | 
1 min read

Resverlogix Corp. (TSX-V:RVX) today announced the appointment of Jan O. Johansson, M.D., Ph.D., as Senior Vice President of Clinical Affairs.

People
MORE ON THIS TOPIC
Facade of AstraZeneca's office in Shanghai, China
Collaboration
AstraZeneca Sets Sights and $1.35B on Subcutaneous Cancer Drugs With Alteogen Alliance
March 18, 2025
 · 
2 min read
 · 
Tristan Manalac
Invest in best idea Investment and analysis money cash profits metaphor Flat tiny people and business concept for trading Economical wealth revenue visualized as growing on a tree vector illustration Field of Dreams
Gene editing
Arbor Raises $73.5M To Ride Out Gene Editing’s ‘Gartner Hype Cycle’
March 18, 2025
 · 
4 min read
 · 
Dan Samorodnitsky
A big businessman hands over the key to the house. Art collage, hand with keys.
Mergers & acquisitions
Taiho Pharmaceutical Buys ADC Partner Araris for up to $1.1B Total
March 17, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
AstraZeneca's sign on its office in California
Mergers & acquisitions
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
March 17, 2025
 · 
2 min read
 · 
Tristan Manalac